Correlation Between Palantir Technologies and Genmab AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Palantir Technologies and Genmab AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Palantir Technologies and Genmab AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Palantir Technologies Class and Genmab AS, you can compare the effects of market volatilities on Palantir Technologies and Genmab AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Palantir Technologies with a short position of Genmab AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Palantir Technologies and Genmab AS.

Diversification Opportunities for Palantir Technologies and Genmab AS

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Palantir and Genmab is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Palantir Technologies Class and Genmab AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genmab AS and Palantir Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Palantir Technologies Class are associated (or correlated) with Genmab AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genmab AS has no effect on the direction of Palantir Technologies i.e., Palantir Technologies and Genmab AS go up and down completely randomly.

Pair Corralation between Palantir Technologies and Genmab AS

Given the investment horizon of 90 days Palantir Technologies Class is expected to generate 1.49 times more return on investment than Genmab AS. However, Palantir Technologies is 1.49 times more volatile than Genmab AS. It trades about 0.13 of its potential returns per unit of risk. Genmab AS is currently generating about -0.05 per unit of risk. If you would invest  1,579  in Palantir Technologies Class on September 3, 2024 and sell it today you would earn a total of  5,060  from holding Palantir Technologies Class or generate 320.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Palantir Technologies Class  vs.  Genmab AS

 Performance 
       Timeline  
Palantir Technologies 

Risk-Adjusted Performance

24 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Palantir Technologies Class are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. Even with relatively abnormal basic indicators, Palantir Technologies reported solid returns over the last few months and may actually be approaching a breakup point.
Genmab AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genmab AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Palantir Technologies and Genmab AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Palantir Technologies and Genmab AS

The main advantage of trading using opposite Palantir Technologies and Genmab AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Palantir Technologies position performs unexpectedly, Genmab AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genmab AS will offset losses from the drop in Genmab AS's long position.
The idea behind Palantir Technologies Class and Genmab AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency